Ishita Drugs & Industries has informed about disclosures under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for the Company received from Abha Agrawal.
The above information is a part of company’s filings submitted to BSE.